BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 1339082)

  • 1. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.
    Groopman JD; Hall AJ; Whittle H; Hudson GJ; Wogan GN; Montesano R; Wild CP
    Cancer Epidemiol Biomarkers Prev; 1992; 1(3):221-7. PubMed ID: 1339082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China.
    Groopman JD; Zhu JQ; Donahue PR; Pikul A; Zhang LS; Chen JS; Wogan GN
    Cancer Res; 1992 Jan; 52(1):45-52. PubMed ID: 1727385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa.
    Wild CP; Hudson GJ; Sabbioni G; Chapot B; Hall AJ; Wogan GN; Whittle H; Montesano R; Groopman JD
    Cancer Epidemiol Biomarkers Prev; 1992; 1(3):229-34. PubMed ID: 1339083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography.
    Groopman JD; Hasler JA; Trudel LJ; Pikul A; Donahue PR; Wogan GN
    Cancer Res; 1992 Jan; 52(2):267-74. PubMed ID: 1728400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
    Yu MW; Lien JP; Liaw YF; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.
    Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aflatoxin exposure measured by urinary excretion of aflatoxin B1-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya.
    Autrup H; Seremet T; Wakhisi J; Wasunna A
    Cancer Res; 1987 Jul; 47(13):3430-3. PubMed ID: 3034416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans.
    Groopman JD; Wild CP; Hasler J; Junshi C; Wogan GN; Kensler TW
    Environ Health Perspect; 1993 Mar; 99():107-13. PubMed ID: 8319607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of aflatoxin-B1-N7-Guanine in human urine by high-performance liquid chromatography and isotope dilution tandem mass spectrometry.
    Egner PA; Groopman JD; Wang JS; Kensler TW; Friesen MD
    Chem Res Toxicol; 2006 Sep; 19(9):1191-5. PubMed ID: 16978023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification and validation of enzyme immunoassay for urinary aflatoxin B1-N7-guanine adduct for biological monitoring of aflatoxins.
    Nayak S; Sashidhar RB; Bhat RV
    Analyst; 2001 Feb; 126(2):179-83. PubMed ID: 11235100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China.
    Wang JS; Huang T; Su J; Liang F; Wei Z; Liang Y; Luo H; Kuang SY; Qian GS; Sun G; He X; Kensler TW; Groopman JD
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):143-6. PubMed ID: 11219772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal and urinary excretion of aflatoxin B1 metabolites (AFQ1, AFM1 and AFB-N7-guanine) in young Chinese males.
    Mykkänen H; Zhu H; Salminen E; Juvonen RO; Ling W; Ma J; Polychronaki N; Kemiläinen H; Mykkänen O; Salminen S; El-Nezami H
    Int J Cancer; 2005 Jul; 115(6):879-84. PubMed ID: 15723309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of dietary aflatoxin B1 levels with excretion of aflatoxin M1 in human urine.
    Zhu JQ; Zhang LS; Hu X; Xiao Y; Chen JS; Xu YC; Fremy J; Chu FS
    Cancer Res; 1987 Apr; 47(7):1848-52. PubMed ID: 3102051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatocellular carcinoma: a preventable cancer].
    Viviani S; Jack A; Bah E; Montesano R
    Epidemiol Prev; 1997; 21(2):129-36. PubMed ID: 9378180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
    Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do aflatoxin-DNA adduct measurements in humans provide accurate data for cancer risk assessment?
    Groopman JD
    IARC Sci Publ; 1988; (89):55-62. PubMed ID: 3143672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China.
    Yeh FS; Yu MC; Mo CC; Luo S; Tong MJ; Henderson BE
    Cancer Res; 1989 May; 49(9):2506-9. PubMed ID: 2539905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct synthesis of aflatoxin B1-N7 guanine adduct: a reference standard for biological monitoring of dietary aflatoxin exposure in molecular epidemiological studies.
    Vidyasagar T; Sujatha N; Sashidhar RB
    Food Addit Contam; 1997 Jul; 14(5):457-67. PubMed ID: 9328530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma.
    Chen CJ; Zhang YJ; Lu SN; Santella RM
    Hepatology; 1992 Nov; 16(5):1150-5. PubMed ID: 1385290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.
    Qian GS; Ross RK; Yu MC; Yuan JM; Gao YT; Henderson BE; Wogan GN; Groopman JD
    Cancer Epidemiol Biomarkers Prev; 1994; 3(1):3-10. PubMed ID: 8118382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.